Bank of America’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.2K Sell
414
-2,121
-84% -$11.3K ﹤0.01% 6383
2025
Q1
$11.2K Sell
2,535
-11,847
-82% -$52.4K ﹤0.01% 6054
2024
Q4
$101K Buy
14,382
+11,168
+347% +$78.2K ﹤0.01% 5523
2024
Q3
$46.6K Buy
3,214
+299
+10% +$4.34K ﹤0.01% 5675
2024
Q2
$213K Buy
2,915
+218
+8% +$15.9K ﹤0.01% 5043
2024
Q1
$160K Sell
2,697
-971
-26% -$57.5K ﹤0.01% 5163
2023
Q4
$269K Buy
3,668
+83
+2% +$6.08K ﹤0.01% 5009
2023
Q3
$139K Sell
3,585
-830
-19% -$32.2K ﹤0.01% 5233
2023
Q2
$255K Buy
4,415
+671
+18% +$38.7K ﹤0.01% 4855
2023
Q1
$243K Buy
3,744
+1,710
+84% +$111K ﹤0.01% 5054
2022
Q4
$55.9K Buy
2,034
+63
+3% +$1.73K ﹤0.01% 5669
2022
Q3
$57K Sell
1,971
-16,222
-89% -$469K ﹤0.01% 5775
2022
Q2
$349K Buy
18,193
+12,604
+226% +$242K ﹤0.01% 4972
2022
Q1
$454K Buy
5,589
+2,744
+96% +$223K ﹤0.01% 5191
2021
Q4
$260K Buy
2,845
+1,839
+183% +$168K ﹤0.01% 5536
2021
Q3
$125K Sell
1,006
-132
-12% -$16.4K ﹤0.01% 5737
2021
Q2
$128K Sell
1,138
-1,054
-48% -$119K ﹤0.01% 5594
2021
Q1
$332K Buy
2,192
+840
+62% +$127K ﹤0.01% 5045
2020
Q4
$155K Sell
1,352
-138
-9% -$15.8K ﹤0.01% 5031
2020
Q3
$115K Sell
1,490
-318
-18% -$24.5K ﹤0.01% 4999
2020
Q2
$199K Sell
1,808
-3,044
-63% -$335K ﹤0.01% 4708
2020
Q1
$531K Sell
4,852
-5,491
-53% -$601K ﹤0.01% 3960
2019
Q4
$1.64M Sell
10,343
-787
-7% -$125K ﹤0.01% 3566
2019
Q3
$1.64M Buy
11,130
+1,006
+10% +$149K ﹤0.01% 3571
2019
Q2
$1.18M Buy
10,124
+1,601
+19% +$186K ﹤0.01% 3822
2019
Q1
$921K Buy
8,523
+8,192
+2,475% +$885K ﹤0.01% 3944
2018
Q4
$26K Buy
331
+258
+353% +$20.3K ﹤0.01% 5655
2018
Q3
$12K Buy
73
+58
+387% +$9.53K ﹤0.01% 5886
2018
Q2
$3K Buy
+15
New +$3K ﹤0.01% 6126